Text Size

Treatment of Late-life Anxiety in Primary Care Settings

This study has been completed.
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by:
Wake Forest University Baptist Medical Center
ClinicalTrials.gov Identifier:
NCT00938093
First received: July 10, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
  Purpose

The research study proposed is designed to examine the outcomes of a cognitive behavioral guided self-care intervention with older adults diagnosed with generalized anxiety disorder and recruited from a primary care setting. It is hypothesized that the cognitive behavioral guided self-care intervention will produce greater declines in worry and anxiety than enhanced usual care.


Condition Intervention Phase
Generalized Anxiety Disorder
Panic Disorder
Anxiety Disorder Not Otherwise Specified
 Behavioral: Cognitive behavioral therapy
Behavioral: Enhanced usual care
 Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Treatment of Late-life Anxiety in Primary Care Settings

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Wake Forest University Baptist Medical Center:

Enrollment: 60
Study Start Date: March 2006
Study Completion Date: February 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Cognitive behavioral therapy
    Participants receive 10 telephone therapy sessions and an accompanying workbook focused on cognitive-behavioral techniques for managing anxiety.
    Behavioral: Enhanced usual care
    Participants receive written information about anxiety, referrals for treatment, and an optional letter to their primary care physician.
  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age ≥ 60 years
  • a DSM-IV diagnosis of GAD
  • able to read English.

Exclusion Criteria:

  • current psychotherapy
  • a DSM-IV diagnosis of alcohol or substance abuse
  • a diagnosis of dementia or global cognitive impairment operationalized as a score of < 24 of the Mini-Mental Status Examination
  • psychotic symptoms
  • active suicidal ideation
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Gretchen A. Brenes, Ph.D. Associate Professor, Wake Forest Univeristy School of Medicine
ClinicalTrials.gov Identifier: NCT00938093     History of Changes
Other Study ID Numbers: MH65281, MH65281
Study First Received: July 10, 2009
Last Updated: July 10, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Anxiety Disorders
Panic Disorder
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013